Playback speed
10 seconds
ESMO 2023 Insights: "Neoadjuvant Cemiplimab for Stage II to IV CSCC - One-Year Follow-Up"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Neil Gross
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Neil Gross
192 views
November 13, 2023
Login to view comments.
Click here to Login